08Jun
FDA Signals a Deliberative Approach to Cannabis at Public Hearing
While it was ostensibly convened to gather scientific input from stakeholders on how to appropriately regulate cannabis-infused products, the Food and Drug Administration (FDA) also used the May 31, 2019 public hearing as a platform to issue a call...
By:
Wilson Sonsini Goodrich & Rosati
Related
Just before Thanksgiving, the First Circuit Court of Appeals handed a “win” to Sun Capital’s priv...
Read More >
If you have been involved in a multivehicle car accident, making sure you receive just compensation ...
Read More >
Under current EU merger control rules, whether a concentration has to be notified to the European Co...
Read More >
The Internal Revenue Service and the Social Security Administration have announced the cost of livin...
Read More >
One of the primary responsibilities of the National Labor Relations Board (NLRB) is conducting secre...
Read More >
Jones Day's global anti-human trafficking initiative promotes unprecedented collaboration between ou...
Read More >